webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Me-Tet-PEG2-COOH

  CAS No.: 2741759-99-7   Cat No.: BADC-01802 4.5  

Me-Tet-PEG2-COOH is a methyl-tetrazine functionalized PEG2 ADC linker with carboxyl group, enabling rapid inverse electron-demand Diels-Alder conjugation for stable payload attachment in antibody-drug conjugates. Keywords: ADC linker, methyl-tetrazine linker, PEG spacer, bioorthogonal chemistry, payload delivery.

Me-Tet-PEG2-COOH

Structure of 2741759-99-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C18H23N5O5
Molecular Weight
389.41

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Methyltetrazine-CH2NHCO-PEG2-CH2CH2COOH
IUPAC Name
3-[2-[3-[[4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl]methylamino]-3-oxopropoxy]ethoxy]propanoic acid
Canonical SMILES
CC1=NN=C(N=N1)C2=CC=C(C=C2)CNC(=O)CCOCCOCCC(=O)O
InChI
InChI=1S/C18H23N5O5/c1-13-20-22-18(23-21-13)15-4-2-14(3-5-15)12-19-16(24)6-8-27-10-11-28-9-7-17(25)26/h2-5H,6-12H2,1H3,(H,19,24)(H,25,26)
InChIKey
FLJWYRUCTSWYAU-UHFFFAOYSA-N

Me-Tet-PEG2-COOH is a versatile chemical compound used in various bioconjugation and drug delivery applications. Here are some key applications of Me-Tet-PEG2-COOH:

Bioconjugation: Me-Tet-PEG2-COOH is utilized in bioconjugation processes where it serves as a linker to join proteins, peptides, or other biomolecules. The PEG (polyethylene glycol) moiety provides hydrophilicity, enhancing solubility and stability. This improves the functionality and bioactivity of therapeutics and diagnostic agents in biological environments.

Drug Delivery Systems: In the field of drug delivery, Me-Tet-PEG2-COOH is employed to design delivery vehicles that enhance the solubility and bioavailability of drugs. The PEGylation effect helps in reducing immunogenicity and prolonging the circulation half-life of drugs. This allows for the development of more effective and targeted pharmaceutical therapies.

Surface Modification: Me-Tet-PEG2-COOH can be used to modify the surfaces of nanoparticles and other materials to improve their biocompatibility. By attaching to these surfaces, it prevents protein adsorption and reduces non-specific interactions with biological systems. This is crucial in applications such as biosensors and medical implants, where minimizing immune responses is essential.

Research and Development: In research, Me-Tet-PEG2-COOH is a valuable tool for developing model systems to study the effects of PEGylation on biological interactions. It provides insights into how modifying biomolecules with PEG chains influences their behavior in biological assays. This application is fundamental for advancing the understanding of PEGylated compounds and designing new bioconjugation strategies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N-Boc-cis-4-hydroxy-L-proline | N-Boc-cis-4-Hydroxy-D-proline | Fmoc-D-Dbu(N3)-OH | SC209 intermediate-2 | Boc-cis-L-4-hydroxyproline methyl ester | EC1167 hydrochloride | Fmoc-D-Trp(Boc)-OH | MAL-tri-EG-OPFP | Methyl azetidine-3-carboxylate hydrochloride | Hydroxy-PEG3-t-butyl ester | Me-Tet-PEG2-COOH
Send Inquiry
Verification code
Inquiry Basket